Zymeworks
ZYME
127 hedge funds and large institutions have $1.61B invested in Zymeworks in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 44 increasing their positions, 40 reducing their positions, and 30 closing their positions.
159% more call options, than puts
Call options by funds: $50M | Put options by funds: $19.3M
30% more capital invested
Capital invested by funds: $1.24B → $1.61B (+$376M)
10% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 40
0.85% more ownership
Funds ownership: 75.56% → 76.41% (+0.85%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 133 → 127 (-6)
20% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 30
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$28.2M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$20.6M |
| 3 |
Goldman Sachs
New York
|
+$17.6M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$13.8M |
| 5 |
HM
HealthCor Management
New York
|
+$11.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$34.6M |
| 2 |
Renaissance Technologies
New York
|
-$18.7M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
-$18.2M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$11.4M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$10.8M |
ZYME Hedge Fund Activity: Q3 2020 in Review
127 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q3 2020, worth a combined $1.61B — up 30% from $1.24B a quarter earlier.
Sellers outnumbered buyers: 30 funds closed out of ZYME and 24 opened new positions — a net loss of 6 holders — while 40 trimmed existing stakes and 44 added.
The largest buyer was Perceptive Advisors, adding an estimated $28.2M. The largest seller was Great Point Partners, cutting an estimated $34.6M.
- 127 institutional investors held Zymeworks (ZYME) as of Q3 2020, down from 133 in Q2 2020.
- Funds reported $1.61B of Zymeworks stock for Q3 2020, up 30% quarter-over-quarter.
- 24 funds opened new Zymeworks positions in Q3 2020 and 30 closed out, a net change of -6 holders.
- The largest Zymeworks buyer in Q3 2020 was Perceptive Advisors, an estimated $28.2M added.
- The largest Zymeworks seller in Q3 2020 was Great Point Partners, an estimated $34.6M sold.
Based on aggregated 13F filings for Q3 2020.